SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3PO'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1P7L_C_SAMC685_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.29A	1p7lC-4odjA: 56.0	1p7lC-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1P7L_C_SAMC885_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.28A	1p7lD-4odjA: 56.0	1p7lD-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_A_SAMA385_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.32A	1rg9A-4odjA: 56.1	1rg9A-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_B_SAMB485_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.32A	1rg9B-4odjA: 56.1	1rg9B-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_C_SAMC585_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.33A	1rg9C-4odjA: 56.0	1rg9C-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_C_SAMC685_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.32A	1rg9D-4odjA: 56.0	1rg9D-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OBV_A_SAMA501_0 (S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.25A	2obvA-4odjA: 60.2	2obvA-4odjA: 55.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P02_A_SAMA2_0 (S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.28A	2p02A-4odjA: 60.1	2p02A-4odjA: 56.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MBG_C_ACTC800_0 (FAD-LINKED SULFHYDRYL OXIDASE ALR)	3tvl	THIAMINE-TRIPHOSPHAT ASE (Homo sapiens)	3 / 3	ASP A 145 ARG A 143 ALA A 127	3PO A 231 ( 4.9A) None None	0.71A	3mbgC-3tvlA: undetectable	3mbgC-3tvlA: 19.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TJ7_C_ACTC608_0 (GBAA_1210 PROTEIN)	3tvl	THIAMINE-TRIPHOSPHAT ASE (Homo sapiens)	4 / 5	GLU A 159 ARG A 57 LYS A 65 ARG A 125	3PO A 231 ( 4.3A) 3PO A 231 (-3.0A) 3PO A 231 (-2.7A) 3PO A 231 (-2.9A)	1.08A	3tj7C-3tvlA: 12.6	3tj7C-3tvlA: 30.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TJ7_C_ACTC608_0 (GBAA_1210 PROTEIN)	5a60	INORGANIC TRIPHOSPHATASE (Escherichia coli)	5 / 5	GLU A 6 ARG A 58 LYS A 69 ARG A 126 GLU A 160	MG A 501 (-2.6A) 3PO A1000 (-2.9A) 3PO A1000 (-2.8A) 3PO A1000 (-2.8A) MG A 500 ( 2.0A)	0.89A	3tj7C-5a60A: 15.6	3tj7C-5a60A: 20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TJ7_C_ACTC608_0 (GBAA_1210 PROTEIN)	5a60	INORGANIC TRIPHOSPHATASE (Escherichia coli)	4 / 5	GLU A 162 ARG A 58 LYS A 69 ARG A 126	MG A 501 (-3.0A) 3PO A1000 (-2.9A) 3PO A1000 (-2.8A) 3PO A1000 (-2.8A)	1.17A	3tj7C-5a60A: 15.6	3tj7C-5a60A: 20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CPZ_G_ZMRG1471_1 (NEURAMINIDASE)	3tvl	THIAMINE-TRIPHOSPHAT ASE (Homo sapiens)	5 / 12	ARG A 57 ALA A 192 GLU A 9 GLU A 7 ARG A 125	3PO A 231 (-3.0A) 3PO A 231 ( 4.2A) None 3PO A 231 ( 4.4A) 3PO A 231 (-2.9A)	1.36A	4cpzG-3tvlA: undetectable	4cpzG-3tvlA: 20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K0B_B_SAMB504_1 (S-ADENOSYLMETHIONINE SYNTHASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	5 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-3.3A)	0.33A	4k0bB-4odjA: 26.7	4k0bB-4odjA: 25.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KR3_A_GLYA701_0 (GLYCINE--TRNA LIGASE)	5a60	INORGANIC TRIPHOSPHATASE (Escherichia coli)	4 / 6	ARG A 58 GLU A 162 ARG A 81 GLU A 6	3PO A1000 (-2.9A) MG A 501 (-3.0A) 3PO A1000 (-2.9A) MG A 501 (-2.6A)	1.43A	4kr3A-5a60A: undetectable	4kr3A-5a60A: 22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KR3_A_GLYA701_0 (GLYCINE--TRNA LIGASE)	5a60	INORGANIC TRIPHOSPHATASE (Escherichia coli)	4 / 6	GLU A 6 ARG A 81 GLU A 162 ARG A 126	MG A 501 (-2.6A) 3PO A1000 (-2.9A) MG A 501 (-3.0A) 3PO A1000 (-2.8A)	1.45A	4kr3A-5a60A: undetectable	4kr3A-5a60A: 22.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTT_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.29A	4kttA-4odjA: 53.0	4kttA-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTT_C_SAMC404_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.24A	4kttC-4odjA: 52.8	4kttC-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTV_A_ADNA403_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 12	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.68A	4ktvA-4odjA: 53.0 4ktvB-4odjA: 58.8	4ktvA-4odjA: 56.28 4ktvB-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTV_C_ADNC403_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 11	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.43A	4ktvC-4odjA: 52.8 4ktvD-4odjA: 58.8	4ktvC-4odjA: 56.28 4ktvD-4odjA: 56.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L7I_B_SAMB501_1 (S-ADENOSYLMETHIONINE SYNTHASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	5 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-3.3A)	0.33A	4l7iB-4odjA: 26.3	4l7iB-4odjA: 25.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NDN_A_SAMA407_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.29A	4ndnA-4odjA: 53.4	4ndnA-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NDN_C_SAMC405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 7	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.24A	4ndnC-4odjA: 53.3	4ndnC-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ODJ_A_SAMA500_0 (S-ADENOSYLMETHIONINE SYNTHASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 7	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.00A	4odjA-4odjA: 70.0	4odjA-4odjA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TVT_A_ASCA305_0 (THAUMATIN-1)	5a60	INORGANIC TRIPHOSPHATASE (Escherichia coli)	4 / 5	LYS A 8 GLU A 158 PHE A 124 VAL A 147	3PO A1000 (-2.8A) None 3PO A1000 (-4.8A) None	1.31A	4tvtA-5a60A: undetectable	4tvtA-5a60A: 17.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_J_377J401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	5mza	ERYTHROCYTE MEMBRANE PROTEIN 1 (PFEMP1) (Plasmodium falciparum)	4 / 6	TYR A 880 ASN A 846 LEU A 875 PHE A 783	3PO A1301 (-3.8A) None None None	1.16A	4twdI-5mzaA: undetectable 4twdJ-5mzaA: undetectable	4twdI-5mzaA: 18.67 4twdJ-5mzaA: 18.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5A1I_A_ADNA407_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.24A	5a1iA-4odjA: 60.2	5a1iA-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5A1I_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 7	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.25A	5a1iA-4odjA: 60.2	5a1iA-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T8S_B_SAMB402_1 (S-ADENOSYLMETHIONINE SYNTHASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.15A	5t8sB-4odjA: 55.3	5t8sB-4odjA: 50.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FBN_B_SAMB401_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.24A	6fbnB-4odjA: 52.0	6fbnB-4odjA: 56.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FBO_A_ADNA406_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.23A	6fboA-4odjA: 60.4	6fboA-4odjA: 12.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FBP_B_ADNB404_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 12	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.31A	6fbpA-4odjA: 60.1 6fbpB-4odjA: 53.6	6fbpA-4odjA: 12.32 6fbpB-4odjA: 12.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FCB_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.32A	6fcbA-4odjA: 59.9	6fcbA-4odjA: 56.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FCD_A_ADNA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.23A	6fcdA-4odjA: 60.0	6fcdA-4odjA: 12.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6G6R_A_SAMA406_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 7	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.25A	6g6rA-4odjA: 60.3	6g6rA-4odjA: 56.28

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1P7L_C_SAMC685_0","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.29A","1p7lC-4odjA:56.0",null],["1P7L_C_SAMC885_1","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.28A","1p7lD-4odjA:56.0","1p7lC-4odjA:47.94"],["1RG9_A_SAMA385_0","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.32A","1rg9A-4odjA:56.1","1p7lD-4odjA:47.94"],["1RG9_B_SAMB485_1","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.32A","1rg9B-4odjA:56.1","1rg9A-4odjA:47.94"],["1RG9_C_SAMC585_0","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.33A","1rg9C-4odjA:56.0","1rg9B-4odjA:47.94"],["1RG9_C_SAMC685_1","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.32A","1rg9D-4odjA:56.0","1rg9C-4odjA:47.94"],["2OBV_A_SAMA501_0","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.25A","2obvA-4odjA:60.2","1rg9D-4odjA:47.94"],["2P02_A_SAMA2_0","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.28A","2p02A-4odjA:60.1","2obvA-4odjA:55.90"],["3MBG_C_ACTC800_0","FAD-LINKED SULFHYDRYL OXIDASE ALR","3tvl","THIAMINE-TRIPHOSPHATASE","Homo sapiens",3,"ASP A 145;ARG A 143;ALA A 127","3PO A 231 ( 4.9A);None;None","0.71A","3mbgC-3tvlA:undetectable","2p02A-4odjA:56.28"],["3TJ7_C_ACTC608_0","GBAA_1210 PROTEIN","3tvl","THIAMINE-TRIPHOSPHATASE","Homo sapiens",4,"GLU A 159;ARG A  57;LYS A  65;ARG A 125","3PO A 231 ( 4.3A);3PO A 231 (-3.0A);3PO A 231 (-2.7A);3PO A 231 (-2.9A)","1.08A","3tj7C-3tvlA:12.6","3mbgC-3tvlA:19.23"],["3TJ7_C_ACTC608_0","GBAA_1210 PROTEIN","5a60","INORGANIC TRIPHOSPHATASE","Escherichia coli",5,"GLU A   6;ARG A  58;LYS A  69;ARG A 126;GLU A 160"," MG A 501 (-2.6A);3PO A1000 (-2.9A);3PO A1000 (-2.8A);3PO A1000 (-2.8A); MG A 500 ( 2.0A)","0.89A","3tj7C-5a60A:15.6","3tj7C-3tvlA:30.04"],["3TJ7_C_ACTC608_0","GBAA_1210 PROTEIN","5a60","INORGANIC TRIPHOSPHATASE","Escherichia coli",4,"GLU A 162;ARG A  58;LYS A  69;ARG A 126"," MG A 501 (-3.0A);3PO A1000 (-2.9A);3PO A1000 (-2.8A);3PO A1000 (-2.8A)","1.17A","3tj7C-5a60A:15.6","3tj7C-5a60A:20.32"],["4CPZ_G_ZMRG1471_1","NEURAMINIDASE","3tvl","THIAMINE-TRIPHOSPHATASE","Homo sapiens",5,"ARG A  57;ALA A 192;GLU A   9;GLU A   7;ARG A 125","3PO A 231 (-3.0A);3PO A 231 ( 4.2A);None;3PO A 231 ( 4.4A);3PO A 231 (-2.9A)","1.36A","4cpzG-3tvlA:undetectable","3tj7C-5a60A:20.32"],["4K0B_B_SAMB504_1","S-ADENOSYLMETHIONINE SYNTHASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",5,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-3.3A)","0.33A","4k0bB-4odjA:26.7","4cpzG-3tvlA:20.22"],["4KR3_A_GLYA701_0","GLYCINE--TRNA LIGASE","5a60","INORGANIC TRIPHOSPHATASE","Escherichia coli",4,"ARG A  58;GLU A 162;ARG A  81;GLU A   6","3PO A1000 (-2.9A); MG A 501 (-3.0A);3PO A1000 (-2.9A); MG A 501 (-2.6A)","1.43A","4kr3A-5a60A:undetectable","4k0bB-4odjA:25.11"],["4KR3_A_GLYA701_0","GLYCINE--TRNA LIGASE","5a60","INORGANIC TRIPHOSPHATASE","Escherichia coli",4,"GLU A   6;ARG A  81;GLU A 162;ARG A 126"," MG A 501 (-2.6A);3PO A1000 (-2.9A); MG A 501 (-3.0A);3PO A1000 (-2.8A)","1.45A","4kr3A-5a60A:undetectable","4kr3A-5a60A:22.04"],["4KTT_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.29A","4kttA-4odjA:53.0","4kr3A-5a60A:22.04"],["4KTT_C_SAMC404_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.24A","4kttC-4odjA:52.8","4kttA-4odjA:56.28"],["4KTV_A_ADNA403_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2;S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.68A","4ktvA-4odjA:53.0;4ktvB-4odjA:58.8","4kttC-4odjA:56.28"],["4KTV_C_ADNC403_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2;S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.43A","4ktvC-4odjA:52.8;4ktvD-4odjA:58.8","4ktvA-4odjA:56.28;4ktvB-4odjA:56.28"],["4L7I_B_SAMB501_1","S-ADENOSYLMETHIONINE SYNTHASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",5,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-3.3A)","0.33A","4l7iB-4odjA:26.3","4ktvC-4odjA:56.28;4ktvD-4odjA:56.28"],["4NDN_A_SAMA407_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.29A","4ndnA-4odjA:53.4","4l7iB-4odjA:25.11"],["4NDN_C_SAMC405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.24A","4ndnC-4odjA:53.3","4ndnA-4odjA:56.28"],["4ODJ_A_SAMA500_0","S-ADENOSYLMETHIONINE SYNTHASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.00A","4odjA-4odjA:70.0","4ndnC-4odjA:56.28"],["4TVT_A_ASCA305_0","THAUMATIN-1","5a60","INORGANIC TRIPHOSPHATASE","Escherichia coli",4,"LYS A   8;GLU A 158;PHE A 124;VAL A 147","3PO A1000 (-2.8A);None;3PO A1000 (-4.8A);None","1.31A","4tvtA-5a60A:undetectable","4odjA-4odjA:100.00"],["4TWD_J_377J401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","5mza","ERYTHROCYTE MEMBRANE PROTEIN 1 (PFEMP1)","Plasmodium falciparum",4,"TYR A 880;ASN A 846;LEU A 875;PHE A 783","3PO A1301 (-3.8A);None;None;None","1.16A","4twdI-5mzaA:undetectable;4twdJ-5mzaA:undetectable","4tvtA-5a60A:17.49"],["5A1I_A_ADNA407_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.24A","5a1iA-4odjA:60.2","4twdI-5mzaA:18.67;4twdJ-5mzaA:18.67"],["5A1I_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.25A","5a1iA-4odjA:60.2","5a1iA-4odjA:56.28"],["5T8S_B_SAMB402_1","S-ADENOSYLMETHIONINE SYNTHASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.15A","5t8sB-4odjA:55.3","5a1iA-4odjA:56.28"],["6FBN_B_SAMB401_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.24A","6fbnB-4odjA:52.0","5t8sB-4odjA:50.82"],["6FBO_A_ADNA406_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.23A","6fboA-4odjA:60.4","6fbnB-4odjA:56.04"],["6FBP_B_ADNB404_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.31A","6fbpA-4odjA:60.1;6fbpB-4odjA:53.6","6fboA-4odjA:12.32"],["6FCB_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.32A","6fcbA-4odjA:59.9","6fbpA-4odjA:12.32;6fbpB-4odjA:12.32"],["6FCD_A_ADNA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.23A","6fcdA-4odjA:60.0","6fcbA-4odjA:56.28"],["6G6R_A_SAMA406_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.25A","6g6rA-4odjA:60.3","6fcdA-4odjA:12.32"]]